CapForce Inc. (CFOR)

Market Cap	6.09M -57.4%
Revenue (ttm)	30.20M +481.2%
Net Income	23.48M +97.0%
EPS	2.32 +0.9%
Shares Out	12.18M
PE Ratio	0.22
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	0.5000
Previous Close	0.5000
Day's Range	0.5000 - 0.5000
52-Week Range	0.000001 - 34.0000
Beta	-2,873.05
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 19, 2026

About CapForce

CapForce Inc., a precision medicine company, develops and commercializes molecular microbiology solutions for life threatening infectious diseases in the United States and internationally. The company’s products include Unyvero application cartridges, Unyvero systems, Acuitas AMR Gene Panel test products, and SARS CoV-2 test kits. It also provides laboratory services; collaboration services, including funded software arrangements; and license arrangements services. In addition, the company offers listing sponsorship and consultancy services. Ca...

• Industry: Capital Markets
• Sector: Financials
• Founded: 2001
• Employees: 3
• Stock Exchange: OTCMKTS
• Ticker Symbol: CFOR

Financial Performance

In 2025, CapForce's revenue was $30.20 million, an increase of 481.20% compared to the previous year's $5.20 million. Earnings were $23.48 million, an increase of 106.75%.